LON:CTEC - ConvaTec Group Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 118.55 -1.65 (-1.37 %)
(As of 02/15/2019 04:00 PM ET)
Previous CloseGBX 118.55
Today's RangeGBX 115.30 - GBX 121
52-Week RangeGBX 181.40 - GBX 349.10
Volume20.25 million shs
Average Volume5.44 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes. The company also provides a portfolio of wound dressings that include antimicrobial and foam dressings to manage chronic wounds comprising pressure, venous leg, and diabetic foot ulcers. In addition, it offers devices, accessories, and services consisting of Esteem+ one-piece and Natura+ two-piece advanced pouch ranges for people with an ostomy or stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. Further, the company provides continence and critical care products, including intermittent urinary catheters; advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and a range of disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, and gastroenterology tubes. Additionally, it offers disposable infusion sets to the suppliers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and a range of products to hospitals and the home healthcare sector. The company markets its products through internal sales force, distributors, wholesalers, hospitals, specialist medical stores, pharmacies, and homecare agencies. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 2008 and is headquartered in Reading, the United Kingdom.

Receive CTEC News and Ratings via Email

Sign-up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone44 11 8952 8100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees9,541
OptionableNot Optionable

ConvaTec Group (LON:CTEC) Frequently Asked Questions

What is ConvaTec Group's stock symbol?

ConvaTec Group trades on the London Stock Exchange (LON) under the ticker symbol "CTEC."

How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group?

ConvaTec Group declared a dividend on Thursday, February 14th. Investors of record on Thursday, April 4th will be given a dividend of GBX 3.10 per share on Thursday, May 16th. This represents a yield of 2.58%. The ex-dividend date of this dividend is Thursday, April 4th. This is a positive change from ConvaTec Group's previous dividend of $1.31. The official announcement can be viewed at this link. View ConvaTec Group's Dividend History.

What price target have analysts set for CTEC?

13 equities research analysts have issued 12 month target prices for ConvaTec Group's stock. Their forecasts range from GBX 130 to GBX 249. On average, they anticipate ConvaTec Group's stock price to reach GBX 193.77 in the next year. This suggests a possible upside of 63.4% from the stock's current price. View Analyst Price Targets for ConvaTec Group.

What is the consensus analysts' recommendation for ConvaTec Group?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last year. There are currently 2 sell ratings, 6 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ConvaTec Group.

Has ConvaTec Group been receiving favorable news coverage?

News headlines about CTEC stock have trended neutral recently, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. ConvaTec Group earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term.

Who are some of ConvaTec Group's key competitors?

Who are ConvaTec Group's key executives?

ConvaTec Group's management team includes the folowing people:
  • Mr. Rick D. Anderson, Interim CEO & Non-Exec. Director (Age 58)
  • Mr. Frank M. Schulkes, CFO & Director (Age 57)
  • Mr. John Crosse, VP of Investor Relations
  • Mr. Adam B. Deutsch, Exec. VP of Corp. Devel. & Gen. Counsel
  • Mr. Douglas Le Fort, Sr. VP of Corp. Devel. (Age 53)

How do I buy shares of ConvaTec Group?

Shares of CTEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is ConvaTec Group's stock price today?

One share of CTEC stock can currently be purchased for approximately GBX 118.55.

What is ConvaTec Group's official website?

The official website for ConvaTec Group is http://www.convatecgroup.com.

How can I contact ConvaTec Group?

ConvaTec Group's mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The company can be reached via phone at 44 11 8952 8100.


MarketBeat Community Rating for ConvaTec Group (LON CTEC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  213 (Vote Outperform)
Underperform Votes:  235 (Vote Underperform)
Total Votes:  448
MarketBeat's community ratings are surveys of what our community members think about ConvaTec Group and other stocks. Vote "Outperform" if you believe CTEC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTEC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel